Total 2 articles
AstraZeneca is moving its US listing to the New York Stock Exchange in February 2026. Discover the impact of the AstraZeneca NYSE listing on investors and the pharmaceutical sector.
Novo Nordisk warns of near-term headwinds in international operations for 2026. Despite high demand for Wegovy, pricing and supply issues pose risks to growth.
Advertise with Us
